2017
DOI: 10.1016/j.annemergmed.2017.07.420
|View full text |Cite
|
Sign up to set email alerts
|

349 Epidemiology of Gastrointestinal Therapies Reported to the Poison Centers, 2011 - 2016

Abstract: Conclusions: After its approval, the recommendations and utilization of hydroxocobalamin as therapy have seen a significant increase, while amyl nitrite as therapy has seen a gradual decrease. Sodium nitrite as therapy has seen no change.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles